SLXN

Conviction 45Scan · Mon, Aug 10, 2026

SLXN$1.52-18.72%

ResistanceSupportVol 14

Vol MA14 157.13K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Silexion Therapeutics CorpBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)silexion.com ↗

Price1.52

Change-18.72%

Gap-5.88%

Rel volume0.55×

Avg volume115.95K

Avg $ vol212.32K

SMA 202.19

SMA 502.85

SMA 2002.07

Price vs 50-46.71%

Price vs 200-26.74%

MA stackmixed

50/200 cross—

Supertrenddown · 2.43

RSI (14)33

MACD hist-0.06

MACD cross—

Stoch %K / %D6 / 21

ADX (14)24

+DI / −DI14 / 34

RSI divergence—

MACD divergence—

ATR %+18.51%

ADR %11.50%

52w high8.23

52w low0.2690

From 52w high-81.53%

Above 52w low+465.06%

New 52w highNo

SqueezeOff

Bollinger width69.69%

%B0.06

Donchian pos5.26%

Donchian high2.78

Donchian low1.45

AVWAP (52w high)0.9147

vs AVWAP high+66.17%

AVWAP (52w low)0.5578

vs AVWAP low+172.52%

OBV trendDown

Chaikin MF (20)-0.12

Today vs 20d0.55×

Avg vol (14d)157.13K

Avg vol (20d)115.95K

Avg $ vol (20d)212.32K

Market cap—

RS 3m (vs SPY)+254.61%

RS 6m (vs SPY)+9.73%

RS line new highNo

Trend template2/8

Technical rank10.0

1 week-22.05%

1 month-41.31%

3 months+189.52%

6 months-5.59%

1 year-82.28%

YTD-19.15%

P/E-0.63

P/B25.77

P/S—

P/FCF-0.69

EPS8.96

Div yield—

ROE—

ROA-258.84%

Debt/Eq—

Current1.00

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth27.89%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value5.09M

Revenue—

Net income-2.73M

Gross profit—

Free cash flow-10.83M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out—

Employees13

ListedFri, Aug 16, 2024

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeC

Conviction45 / 100

Pattern quality—

Tech rank10.0 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance2.87

Support1.58

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in SLXN

All disclosures →

No recent disclosed trades by Congress in SLXN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SLXN · 3 buys

Insider	Side	Shares	Value	Traded	Filed
Horenshtein Hadar Mirit CFO and Secretary · Ordinary Shares · 2026-06-04	Grant	7.5K	$0	2026-06-04	2026-06-08
Hadar Ilan Chairman and CEO · Ordinary Shares · 2026-06-04	Grant	10K	$0	2026-06-04	2026-06-08
Shirvan Mitchell CSO and CDO · Ordinary Shares · 2026-06-04	Grant	6K	$0	2026-06-04	2026-06-08
Hadar Ilan Chairman and CEO · Stock Option (right to buy Ordinary Shares) · 2026-06-04	Other	—	—	2026-06-04	2026-06-08
Shirvan Mitchell CSO and CDO · Stock Option (right to buy Ordinary Shares) · 2026-06-04	Other	—	—	2026-06-04	2026-06-08

SEC filings

EDGAR filings in SLXN · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.